Phase 3 Septic Shock Clinical Trials
9 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–9 of 9 trials
Recruiting
Phase 3
Comparative Efficacy and Safety of Propofol-Ketamine Combination Versus Propofol Monotherapy in Geriatric Patients Under Invasive Ventilation
PneumoniaSeptic ShockThe Critically Ill Patient is Requiring Intubation
Helwan University41 enrolled1 locationNCT07530146
Recruiting
Phase 2Phase 3
Early Methylene Blue in the Microhemodynamics of Septic Patients
HypoperfusionSeptic Shock
Centro de Estudos e Pesquisa em Emergencias Medicas e Terapia Intensiva50 enrolled1 locationNCT07264543
Recruiting
Phase 3
Norepinephrine and Vasopressin for Rescue Versus Early Vasopressin for Vasopressor Dependent Sepsis
Septic Shock
Hospital do Coracao2,800 enrolled8 locationsNCT06464510
Recruiting
Phase 3
Weaning Approaches for Vasopressin in Sepsis
Septic Shock
Hospital Nossa Senhora da Conceicao82 enrolled1 locationNCT07067866
Recruiting
Phase 3
Stress Hydrocortisone In Pediatric Septic Shock
Septic Shock
Jerry Zimmerman500 enrolled44 locationsNCT03401398
Recruiting
Phase 3
Comparison of Landiolol Versus Standard of Care for Prevention of Mortality in Patients Hospitalized for a Septic Shock With Hypercontractility
Septic ShockTachycardiaMortality During Septic Shock+1 more
Centre Hospitalier Universitaire, Amiens360 enrolled1 locationNCT04748796
Recruiting
Phase 3
LANdiolol MIcrocirculatory Effects During Septic chOc (MILANOS)
Septic Shock
Assistance Publique - Hôpitaux de Paris44 enrolled1 locationNCT04931225
Recruiting
Phase 3
A Phase III, Open Label, Randomized, Controlled Study of VBI-S in the Treatment of Hypovolemia in Patients With Septic Shock (VBI-S-02)
SepsisSeptic ShockHypovolemia
Vivacelle Bio46 enrolled6 locationsNCT06072430
Recruiting
Phase 3
Piperacillin-tazobactam and Temocillin as Carbapenem-alternatives for the Treatment of Severe Infections Due to Extended-spectrum Beta-lactamase-Producing Gram-negative Enterobacteriaceae in the Intensive Care Unit
SepsisSeptic Shock
Assistance Publique - Hôpitaux de Paris600 enrolled2 locationsNCT05565222